Description
Aminalon Pharmacodynamics
Nootropic, improves metabolic processes of brain tissue, promotes utilization of glucose by the brain and removal of toxic products of metabolism. Increases thinking efficiency, improves memory, has a moderate psychostimulant effect, a positive effect on the restoration of movement and speech after impaired cerebral circulation. It has a mild hypotensive effect, reduces initial high blood pressure (BP) and the severity of symptoms caused by hypertension (dizziness, insomnia), and slightly reduces heart rate. It has a moderate antihypoxic and anticonvulsant effect. In diabetic patients it reduces glucose content, while in normal blood glucose content it has the opposite effect (due to glycogenolysis).
Indications
Residual effects of craniocerebral trauma, stroke; cerebrovascular insufficiency, encephalopathies of various genesis, alcoholic encephalopathy, alcoholic polyneuropathy, cerebral palsy, consequences of craniocerebral birth trauma in children over 3 years, mental retardation, symptoms of motion sickness (seasickness and airway disease).
Contraindications
Hypersensitivity to the components of the drug, children under 3 years of age, acute renal failure, sucrose/isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption, celiac disease.
Caution:
Contraindicated in the 1st trimester of pregnancy and during lactation. Application in the II and III trimester of pregnancy is possible by prescription.
Dosage and administration.
- Inside, before a meal. The daily dose for adults – 3-3.75 g for children 4-6 years – 2-3 g / day, older than 7 years – 3 g / day. The daily dose is divided into 3 doses. Treatment is prolonged (from 2-3 weeks to 2-4 months). With residual effects of craniocerebral injury, stroke, cerebrovascular failure and encephalopathy of various genesis, depending on the nature and severity of the disease, 0.25-0.5-1.0 g three times a day for 1-3 months.
- At alcoholic encephalopathy and polyneuropathy doses and duration of treatment are established individually.
- During craniocerebral birth trauma and mental retardation in children aminalon is prescribed in high doses (2-3 g / day) for 2-3 months.
- In order to prevent and treat motion sickness syndrome for adults – 0.5 g, for children – 0.25 g just before transportation, or 3 times a day for 3-4 days.
- Precautions for use
If any of the possible side effects stated in the instructions are aggravated or if you notice any other side effects not stated in the instructions, inform your doctor.
